MYGN R&D to Revenue
Myriad Genetics Inc · R&D to Revenue
MYGN R&D to Revenue
Latest reported12.95%period ending
MYGN FY R&D/Revenue (196.97% → 12.95%)
Latest values, visible window
High-resolution chart · PNG
MYGN r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 12.9533% | |
| 13.5387% | |
| 11.7764% | |
| 12.5884% | |
| 11.8593% | |
| 14.5242% | |
| 12.0889% | |
| 10.0928% | |
| 9.52% | |
| 10.21% | |
| 9.5341% | |
| 10.4412% | |
| 8.6708% | |
| 8.7583% | |
| 8.5977% | |
| 6.9018% | |
| 6.0315% | |
| 5.4862% | |
| 62.6932% | |
| 64.0938% | |
| 73.2917% | |
| 71.8916% | |
| 89.4948% | |
| 73.9867% | |
| 67.4165% | |
| 74.8812% | |
| 82.6118% | |
| 92.8854% | |
| 99.1379% | |
| 122.3684% | |
| 196.9697% |